5 research outputs found
Comparison of the baseline characteristics of the patients with and without GC-DM during hospitalization.
<p>Comparison of the baseline characteristics of the patients with and without GC-DM during hospitalization.</p
Comparison of the baseline characteristics of the patients with and without GC-DM treatment at one year.
<p>Comparison of the baseline characteristics of the patients with and without GC-DM treatment at one year.</p
Schematic illustration of the protocol.
<p>Patients received methylprednisolone (mPSL) pulse (500 mg daily) administered intravenously for 3 consecutive days followed by oral prednisolone (30 mg daily) on 4 consecutive days, with the course repeated 3 times during hospitalization. Oral prednisolone (30 mg) was then given on every alternate day and gradually tapered and discontinued at 1 year.</p
Risk factors for GC-DM.
<p>The multivariate analysis revealed an older age (≥45 years) and a family history of diabetes to be independent risk factors for the development of GC-DM during hospitalization. In a logistic regression analysis, older age (≥45 years) and a family history of diabetes emerged as independent risk factors for the development of GC-DM (odds ratio [OR], 6.3 and 95% confidence interval [CI], 1.6–27.6; OR, 4.4 and 95% CI, 1.2–16.6, respectively).</p
Additional file 1 of Evaluating the safety profile of calcineurin inhibitors: cancer risk in patients with systemic lupus erythematosus from the LUNA registry—a historical cohort study
Additional file 1: Figure S1. Design diagram to clarify the key points of each item